Tata Memorial Hospital

Kutatók

• NKNavin Khattry

Futó vizsgálatok

• Toboroz

  Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow

  NCT06492486· 2. fázis· Tata Memorial Centre· Forrás

• Toboroz

  Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors

  NCT07404176· 2. fázis· Tata Memorial Hospital· Forrás

• Toboroz

  Asian Gynecological Brachytherapy Registry in Cervical Cancer

  NCT07196033· Tata Memorial Hospital· Forrás

• Toboroz

  Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors

  NCT07236840· Tata Memorial Centre· Forrás

• Még nem toboroz

  Affordable Made-in-India Microspheres for Liver Cancer Therapy

  NCT07436988· 1. fázis· Post Graduate Institute of Medical Education and Research, Chandigarh· Forrás

• Toboroz

  Systemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer

  NCT06804135· Tata Memorial Hospital· Forrás

• Toboroz

  A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  NCT06989437· 2/3. fázis· Pfizer· Forrás

• Toboroz

  A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  NCT07144280· 3. fázis· Pfizer· Forrás

• Toboroz

  Intensity Modulated PrOton Therapy in Pediatric BRain Tumors (IMPORT)

  NCT07338526· Tata Memorial Centre· Forrás

• Toboroz

  A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

  NCT07062965· 3. fázis· Pfizer· Forrás

• Toboroz

  Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India

  NCT07044687· 4. fázis· AbbVie· Forrás

• Toboroz

  This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  NCT06758401· 3. fázis· Pfizer· Forrás

• Toboroz

  Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors

  NCT06831461· Tata Memorial Centre· Forrás

• Fut, nem toboroz

  A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma

  NCT07030517· 4. fázis· Johnson & Johnson Private Limited· Forrás

• Toboroz

  Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study

  NCT07435623· Tata Memorial Hospital· Forrás

• Toboroz

  A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  NCT06499285· 3. fázis· Takeda· Forrás

• Toboroz

  Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative

  NCT05774483· Tata Memorial Hospital· Forrás

• Toboroz

  Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  NCT06819007· 3. fázis· Daiichi Sankyo· Forrás

• Toboroz

  Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial

  NCT06818682· 2. fázis· Tata Memorial Centre· Forrás

• Toboroz

  Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline

  NCT06779487· Tata Memorial Centre· Forrás

• Toboroz

  Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma

  NCT06755450· 1. fázis· Aurigene Discovery Technologies Limited· Forrás

• Toboroz

  Tracing Brain Tumors Through Deep Time

  NCT06381531· Tata Memorial Centre· Forrás

• Fut, nem toboroz

  Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

  NCT06760637· 3. fázis· Pfizer· Forrás

• Toboroz

  FAPi PET in Pancreatic Ductal Adenocarcinoma

  NCT07342231· Tata Memorial Hospital· Forrás

• Toboroz

  Craniospinal Irradiation in Histone AlteRed Midline Glioma

  NCT06720727· Tata Memorial Centre· Forrás

• Toboroz

  A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

  NCT06750094· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Impact of Molecular Pathological And Clinical Features for Adjuvant Treatment Selection in Endometrial Cancer: Asian Registry

  NCT07354087· Tata Memorial Hospital· Forrás

• Toboroz

  Asian Watch-and-Wait Database (AWWD)

  NCT06631443· Tata Memorial Centre· Forrás

• Toboroz

  A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

  NCT06662786· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

  NCT06561386· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor

  NCT07755397· 1. fázis· Jubilant Therapeutics India Limited· Forrás

• Toboroz

  Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

  NCT06282575· 3. fázis· Jazz Pharmaceuticals· Forrás

• Toboroz

  A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

  NCT06345729· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Radiation Therapy in Unresectable Gall Bladder Cancer

  NCT06214572· 2/3. fázis· Tata Memorial Centre· Forrás

• Toboroz

  Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC)

  NCT06189209· 2. fázis· Rhizen Pharmaceuticals SA· Forrás

• Toboroz

  Spatial and Temporal Characterization of Gliomas Using Radiomic Analysis

  NCT06036381· Tata Memorial Centre· Forrás

• Fut, nem toboroz

  ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer

  NCT05653063· University College, London· Forrás

• Toboroz

  A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse Glioma

  NCT06016452· 2. fázis· Tata Memorial Centre· Forrás

• Toboroz

  Artificial Intelligence in CNS Radiation Oncology

  NCT06036394· Tata Memorial Centre· Forrás

• Toboroz

  Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study.

  NCT07400809· Tata Memorial Hospital· Forrás

• Toboroz

  Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients

  NCT07062263· 3. fázis· Tata Memorial Centre· Forrás

• Fut, nem toboroz

  SCRT in TNT With or Without Chlorophyllin

  NCT05856305· 2. fázis· Tata Memorial Centre· Forrás

• Toboroz

  Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study

  NCT05857631· Tata Memorial Centre· Forrás

• Fut, nem toboroz

  A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)

  NCT05714202· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer

  NCT05654623· 3. fázis· Pfizer· Forrás

• Fut, nem toboroz

  Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)

  NCT05501886· 3. fázis· Celcuity Inc· Forrás

• Toboroz

  A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)

  NCT05348876· 4. fázis· Bayer· Forrás

• Fut, nem toboroz

  A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma

  NCT05732805· 3. fázis· Biocad· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

  NCT05296798· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer

  NCT05969314· 1. fázis· Tata Memorial Hospital· Forrás

Showing 50 of 84.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok13 toboroz
• Tüdőrák9 toboroz
• Méhnyakrák8 toboroz
• Fej-nyaki daganatok5 toboroz
• Máj- és epeúti rák4 toboroz
• Vastagbélrák4 toboroz
• Petefészekrák3 toboroz
• Áttétes emlőrák2 toboroz
• Glioblasztóma2 toboroz
• Hasnyálmirigyrák2 toboroz
• Hodgkin-limfóma2 toboroz
• Méhtestrák2 toboroz
• Neuroendokrin daganatok2 toboroz
• Prosztatarák2 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Meningioma1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Szarkóma1 toboroz
• Tripla negatív emlőrák1 toboroz

Lezárt vizsgálatok

• Visszavonták

  Incidence of HIV Infection in Screening Indian Men Who Have Sex With Men

  NCT04142385· AIDS Malignancy Consortium· Forrás

• Visszavonták

  Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men

  NCT04142398· AIDS Malignancy Consortium· Forrás

• Lezárult

  Brain Tumor Intraoperative Ultrasound Database

  NCT05062772· Hospital del Rio Hortega· Forrás

• Lezárult

  Sentinel Node Biopsy in Early Oral Cancers a Tertiary Cancer Centre Experience

  NCT05950737· Tata Memorial Hospital· Forrás

• Lezárult

  India HIV-CervCa Project

  NCT07167069· Abramson Cancer Center at Penn Medicine· Forrás

• Lezárult

  A Study to Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine and Oxaliplatin Compared to Rituximab, Gemcitabine and Oxaliplatin Alone in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  NCT04182204· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

  NCT03934684· 4. fázis· Amgen· Forrás

• Lezárult

  Adjuvant Radiotherapy in Early Stage Oral Cancers

  NCT03853655· Tata Memorial Hospital· Forrás

• Lezárult

  Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).

  NCT03564938· 4. fázis· Bayer· Forrás

• Leállították

  A Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck

  NCT03452137· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer

  NCT03573960· 4. fázis· Eisai Pharmaceuticals India Pvt. Ltd· Forrás

• Lezárult

  Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix

  NCT03256916· 3. fázis· Tata Memorial Hospital· Forrás

• Lezárult

  Image Based Brachytherapy in Locally Advanced Cervical Cancers - a Randomized Controlled Trial

  NCT03005743· Tata Memorial Hospital· Forrás

• Leállították

  Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies

  NCT02629692· 1/2. fázis· Sun Pharma Advanced Research Company Limited· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Szarkóma40 munka · 1 vizsgálat
• Méhnyakrák37 munka · 12 vizsgálat
• Gyermekkori daganatok29 munka · 19 vizsgálat
• Fej-nyaki daganatok25 munka · 10 vizsgálat
• Neuroendokrin daganatok20 munka · 3 vizsgálat
• Pajzsmirigyrák14 munka · 1 vizsgálat
• Akut limfoid leukémia (ALL)13 munka · 2 vizsgálat
• Hodgkin-limfóma12 munka · 2 vizsgálat
• Meningioma8 munka · 2 vizsgálat
• Krónikus mieloid leukémia (CML)8 munka · 1 vizsgálat